The incidence of symptomatic venous thromboembolic events in orthopaedic surgery when using routine thromboprophylaxis

Vasa - Journal of Vascular Diseases

Volumn 37, Issue 4, 2008, Pages 353-357

  Milbrink, J ^a   Bergqvist, David ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Low molecular weight heparin; Orthopaedic surgery; Pulmonary embolism; Thromboprophylaxis; Venous thrombosis

Indexed keywords

ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; ORAL CONTRACEPTIVE AGENT; FIBRINOLYTIC AGENT;

ANKLE FRACTURE; ARTICLE; DEEP VEIN THROMBOSIS; EVENING DOSAGE; FEMALE; HIGH RISK POPULATION; HIP FRACTURE; HIP SURGERY; HUMAN; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; SWEDEN; THROMBOSIS PREVENTION; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; VENOUS THROMBOEMBOLISM; RETROSPECTIVE STUDY; TIME;

FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INCIDENCE; ORTHOPEDIC PROCEDURES; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; SWEDEN; TIME FACTORS; VENOUS THROMBOEMBOLISM;

EID: 69949107757     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.37.4.353     Document Type: Article

References (13)

1. Bergqvist D. Assessment of the risk and the prophylaxis of venous thromboembolism in surgical patients. Pathophysiol Haemost Thromb 2003; 33:358-61.
2. Bjornara BT, Gudmundsen TE, Dahl OE. Frequency and timing of clinical venous thromboembolism after major joint surgery. J Bone Joint Surg Br 2006; 88: 386-91.
3. Dahl OE, Gudmundsen TE, Bjornara BT, Solheim DM. Risk of clinical pulmonary embolism after joint surgery in patients receiving low-molecular-weight heparin prophylaxis in hospital: a 10-year prospective register of 3954 patients. Acta Orthop Scand 2003; 74: 299-304.
4. Douketis JD, Eikelboom JW, Quinlan DJ, Willan AR, Crowther MA. Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes. Arch Intern Med 2002; 162: 1465-71.
5. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR,Colwell CW, Ray JG. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 338S-400S.
6. Harenberg J, Piazolo L, Misselwitz F. Prevention of thromboembolism with low-molecular-weight heparin in ambulatory surgery and unoperated surgical and orthopedic patients. Zentralbl Chir 1998; 123: 1284-7.
7. Lassen MR,Borris LC,Nakov RL. Use of the low-molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization. N Engl J Med 2002; 347: 726-30.
8. Nicolaides AN,Arcelus J, Belcaro G, Bergqvist D, Borris LC, Buller HR, Caprini JA, Christopoulos D,Clarke-Pearson D,Clement D, et al. Prevention of venous thromboembolism. European Consensus Statement, 1-5 November 1991, developed at Oakley Court Hotel, Windsor, UK. Int Angiol 1992; 11: 151-9.
9. Rosencher N, Vielpeau C, Emmerich J, Fagnani F, Samama CM. Venous thromboembolism and mortality after hip fracture surgery: the ESCORTE study. J Thromb Haemost 2005;3:2006-14.
10. Schippinger G,Wirnsberger GH, Obernosterer A, Babinski K. Thromboembolic complications after arthroscopic knee surgery. Incidence and risk factors in 101 patients.Acta Orthop Scand 1998; 69: 144-6.
11. Wenzl ME, Hasse W, Seide K, Wolter D. Prevention of thromboembolism with low-molecular-weight heparin in orthopedic surgery: a 5-year experience. Clin Appl Thromb Hemost 2004; 10: 1-4.
12. White RH,Romano PS, Zhou H, Rodrigo J, Bargar W. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med 1998; 158: 1525-31.
13. Wirth T, Schneider B,Misselwitz F, Lomb M, Tuylu H, Egbring R, Griss P. Prevention of venous thromboembolism after knee arthroscopy with low- molecular weight heparin (reviparin): Results of a randomized controlled trial.Arthroscopy 2001; 17: 393-9.